Indication

Immune System Suppression

1 clinical trial

1 product

1 drug

Clinical trial

Prograf/Envarsus Conversion Study in Liver Transplant Recipients to Improve Side Effects, Adherence and Quality of Life: A Single-centre Randomized Controlled Trial

Status: Not yet recruiting, Estimated PCD: 2023-12-31

Drug

Product